Follow
Sharyn Baker
Title
Cited by
Cited by
Year
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
J Verweij, PG Casali, J Zalcberg, A LeCesne, P Reichardt, JY Blay, ...
The Lancet 364 (9440), 1127-1134, 2004
20892004
American Society of Clinical Oncology treatment of unresectable non–small-cell lung cancer guideline: Update 2003
DG Pfister, DH Johnson, CG Azzoli, W Sause, TJ Smith, S Baker Jr, J Olak, ...
Journal of Clinical Oncology 22 (2), 330-353, 2004
18952004
American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non–small-cell lung cancer
CG Azzoli, S Baker Jr, S Temin, W Pao, T Aliff, J Brahmer, DH Johnson, ...
Journal of clinical oncology 27 (36), 6251, 2009
9712009
The genomic landscape of hypodiploid acute lymphoblastic leukemia
L Holmfeldt, L Wei, E Diaz-Flores, M Walsh, J Zhang, L Ding, ...
Nature genetics 45 (3), 242-252, 2013
7782013
CREBBP mutations in relapsed acute lymphoblastic leukaemia
CG Mullighan, J Zhang, LH Kasper, S Lerach, D Payne-Turner, ...
Nature 471 (7337), 235-239, 2011
6942011
Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update
GA Masters, S Temin, CG Azzoli, G Giaccone, S Baker Jr, JR Brahmer, ...
Journal of Clinical Oncology 33 (30), 3488, 2015
5392015
Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
American Society of Clinical Oncology
Journal of Clinical Oncology 15 (8), 2996-3018, 1997
4941997
2011 focused update of 2009 American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non–small-cell lung cancer
CG Azzoli, S Temin, G Giaccone
Journal of oncology practice 8 (1), 63-66, 2012
4282012
Differential metabolism of gefitinib and erlotinib by human cytochrome P450 enzymes
J Li, M Zhao, P He, M Hidalgo, SD Baker
Clinical Cancer Research 13 (12), 3731-3737, 2007
3382007
Irinotecan pathway genotype analysis to predict pharmacokinetics
RHJ Mathijssen, S Marsh, MO Karlsson, R Xie, SD Baker, J Verweij, ...
Clinical cancer research 9 (9), 3246-3253, 2003
3222003
Role of body surface area in dosing of investigational anticancer agents in adults, 1991–2001
SD Baker, J Verweij, EK Rowinsky, RC Donehower, JHM Schellens, ...
Journal of the National Cancer Institute 94 (24), 1883-1888, 2002
3202002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy
C Niyikiza, SD Baker, DE Seitz, JM Walling, K Nelson, JJ Rusthoven, ...
Molecular cancer therapeutics 1 (7), 545-552, 2002
3202002
An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors
ML Amador, D Oppenheimer, S Perea, A Maitra, G Cusati, ...
Cancer Research 64 (24), 9139-9143, 2004
3102004
Absorption, Metabolism, and Excretion of 14C-Temozolomide following Oral Administration to Patients with Advanced Cancer
SD Baker, M Wirth, P Statkevich, P Reidenberg, K Alton, SE Sartorius, ...
Clinical Cancer Research 5 (2), 309-317, 1999
3041999
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies
J Gilbert, SD Baker, MK Bowling, L Grochow, WD Figg, Y Zabelina, ...
Clinical Cancer Research 7 (8), 2292-2300, 2001
3002001
Pharmacogenetics of ABCG2 and adverse reactions to gefitinib
G Cusatis, V Gregorc, J Li, A Spreafico, RG Ingersoll, J Verweij, ...
Journal of the National Cancer Institute 98 (23), 1739-1742, 2006
2842006
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial
K Tanabe, PW Serruys, M Degertekin, E Grube, G Guagliumi, W Urbaszek, ...
Circulation 111 (7), 900-905, 2005
2672005
Interaction of imatinib with human organic ion carriers
S Hu, RM Franke, KK Filipski, C Hu, SJ Orwick, EA De Bruijn, H Burger, ...
Clinical Cancer Research 14 (10), 3141-3148, 2008
2632008
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel
MO Bradley, NL Webb, FH Anthony, P Devanesan, PA Witman, ...
Clinical Cancer Research 7 (10), 3229-3238, 2001
2632001
The influence of protein binding upon tissue fluid levels of six β-lactam antibiotics
R Wise, AP Gillett, B Cadge, SR Durham, S Baker
Journal of Infectious Diseases 142 (1), 77-82, 1980
2161980
The system can't perform the operation now. Try again later.
Articles 1–20